Celularity (CELU) Current Assets (2018 - 2025)
Celularity (CELU) posted quarterly Current Assets of $12.3 million for Q4 2025, down 40.09% year-over-year from $20.6 million in Q4 2024, and up 16.26% quarter-over-quarter from $10.6 million in Q3 2025.
Celularity (CELU) Current Assets (2018 - 2025) Analysis & Trends
Celularity (CELU) has reported Current Assets for 8 consecutive years, with $12.3 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Assets fell 40.09% year-over-year to $12.3 million; the TTM figure through Dec 2025 stood at $12.3 million (down 40.09% YoY), while the FY2025 annual figure was $12.3 million, down 40.09% from the prior year.
- Current Assets grew to $12.3 million in Q4 2025 per CELU's latest filing, from $10.6 million in the prior quarter.
- Across five years, Current Assets topped out at $91.3 million in Q3 2021 and bottomed at $57811.0 in Q2 2021.
- Historically, Current Assets has averaged $30.8 million across 5 years, with a median of $20.2 million in 2023.
- Annual changes were most pronounced in 2021 — Current Assets tumbled 92.91% — and 2022, when it soared 130416.68%.
- Celularity's Current Assets stood at $59.1 million in 2021, then sank by 43.31% to $33.5 million in 2022, then plunged by 40.92% to $19.8 million in 2023, then climbed by 3.88% to $20.6 million in 2024, then sank by 40.09% to $12.3 million in 2025.
- Business Quant data shows CELU's Current Assets at $12.3 million in Q4 2025, $10.6 million in Q3 2025, and $17.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | Celularity | 20.99 Mn | 14.82 Mn | -3.27 Mn | 12.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.32 Mn |
| Sep 30, 2025 | 10.60 Mn |
| Jun 30, 2025 | 17.26 Mn |
| Mar 31, 2025 | 22.08 Mn |
| Dec 31, 2024 | 20.56 Mn |
| Sep 30, 2024 | 14.50 Mn |
| Jun 30, 2024 | 17.73 Mn |
| Mar 31, 2024 | 22.86 Mn |
| Dec 31, 2023 | 19.79 Mn |
| Sep 30, 2023 | 16.50 Mn |
| Jun 30, 2023 | 18.04 Mn |
| Mar 31, 2023 | 25.00 Mn |
| Dec 31, 2022 | 33.50 Mn |
| Sep 30, 2022 | 63.10 Mn |
| Jun 30, 2022 | 75.45 Mn |
| Mar 31, 2022 | 75.74 Mn |
| Dec 31, 2021 | 59.10 Mn |
| Sep 30, 2021 | 91.28 Mn |
| Jun 30, 2021 | 57,811.00 |
| Mar 31, 2021 | 99,501.00 |